Search Results for "Gsk573719"
Original Source: 24-week Trial Comparing GSK573719/GW642444 With GW642444 and With Tiotropium in Chronic Obstructive Pulmonary Disease
This is a Phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of two doses of GSK573719/GW642444 Inhalation Powder and GW642444 Inhalation Powder via a Novel Dry Powder Inhaler and tiotropium via HandiHaler when administered once-daily over a 24-week treatment period in subjects with chronic obstructive pulmonary disease (COPD). Subjects who meet eligibility criteria at Screening (Visit 1) will complete a 7 to1...
Matching Channels
None
Matching News
Theravance, GSK report Phase IIIa COPD data
Theravance Inc. (NASDAQ:THRX) gained $2.49 (11%) to $24.71 after the company and partner GlaxoSmithKline plc (LSE:GSK; NYSE:GSK) reported positive data from four Phase IIIa trials evaluating once-dail...
GSK573719/vilanterol: Phase IIIa data
GSK and Theravance Announce Regulatory Submission for UMEC/VI (LAMA/LABA) in the US
LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 12/18/12 -- GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application in the US fo...
GSK and Theravance Announce Regulatory Submission for ANORO(TM) (UMEC/VI) in Europe
LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 01/09/13 -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application in the...
GSK and Theravance Announce Regulatory Submission for ANORO(TM) ELLIPTA(TM) (UMEC/VI) in Japan
LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwired) -- 04/22/13 -- GlaxoSmithKline plc (GSK) and Theravance, Inc. (NASDAQ: THRX) today announced the submission of a regulatory application to the Japa...
LONDON and SOUTH SAN FRANCISCO, CA -- (Marketwire) -- 02/19/13 -- GlaxoSmithKline plc (LSE: GSK) and Theravance, Inc. (NASDAQ: THRX) today announced that the New Drug Application (NDA) for the invest...
Matching PubMed Articles
None
